Connect with us

Business

Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval – Reuters

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s…

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agencys decision to approve Biogen Incs (BIIB.O) Alzheimers disease treatment despite the committees recommendation against doing so.

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Wondering if the Covid Vaccine Worked? Get the Right Test, at the Right Time – The New York Times
Article feature image
Early Amazon Prime Day 2021 deals: Instant Pots, Roku, and AirPods – Business Insider
Article feature image
Former SEC chair on the market risks even meme stock traders can’t afford to ignore – CNBC